Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer

Por Carole Mercier, Carole Mercier, Marc Claessens, Bart De Troyer, Tibaut Debacker, Karen Fransis, Hendrik Vandeursen, Piet Ost, Piet Ost, Piet Dirix, Piet Dirix
Publicado em 2022-04-01

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial

Por Valérie Fonteyne, Piet Dirix, Sara Junius, Elke Rammant, Piet Ost, Gert De Meerleer, Martijn Swimberghe, Karel Decaestecker
Publicado em 2017-05-01

Precision of image-guided spinal stereotactic ablative radiotherapy and impact of positioning variables

Por Charlotte Billiet, Wim Vingerhoed, Steven Van Laere, Ines Joye, Carole Mercier, Piet Dirix, Daan Nevens, Peter Vermeulen, Paul Meijnders, Dirk Verellen
Publicado em 2022-04-01

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Por Sandra Tuyaerts, An M. T. Van Nuffel, Eline Naert, Peter A. Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, Frédéric Amant, Katrien Vandecasteele, Hannelore Denys
Publicado em 2019-05-01

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers

Por François Bertucci, Charlotte Rypens, Pascal Finetti, Arnaud Guille, José Adélaïde, Audrey Monneur, Nadine Carbuccia, Séverine Garnier, Piet Dirix, Anthony Gonçalves, Peter Vermeulen, Bisrat G. Debeb, Xiaoping Wang, Luc Dirix, Naoto T. Ueno, Patrice Viens, Massimo Cristofanilli, Max Chaffanet, Daniel Birnbaum, Steven Van Laere
Publicado em 2020-03-01